ACS Nano,
Journal Year:
2024,
Volume and Issue:
18(27), P. 17749 - 17763
Published: June 27, 2024
The
rapid
development
of
the
SARS-CoV-2
vaccine
has
been
used
to
prevent
spread
coronavirus
2019
(COVID-19).
However,
ongoing
and
future
pandemics
caused
by
variants
mutations
underscore
need
for
effective
vaccines
that
provide
broad-spectrum
protection.
Here,
we
developed
a
nanoparticle
with
broad
protection
against
divergent
variants.
corresponding
conserved
epitopes
preexisting
neutralizing
(CePn)
antibody
were
presented
on
self-assembling
Helicobacter
pylori
ferritin
generate
CePnF
nanoparticle.
Intranasal
immunization
mice
nanoparticles
induced
robust
humoral,
cellular,
mucosal
immune
responses
long-lasting
immunity.
CePnF-induced
antibodies
exhibited
cross-reactivity
activity
different
coronaviruses
(CoVs).
vaccination
significantly
inhibited
replication
pathology
Delta,
WIV04,
Omicron
strains
in
hACE2
transgenic
and,
thus,
conferred
these
Our
constructed
nanovaccine
targeting
can
serve
as
promising
candidate
universal
vaccine.
Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: June 25, 2024
Abstract
Cell
spheroids
(esp.
organoids)
as
3D
culture
platforms
are
popular
models
for
representing
cell–cell
and
cell–extracellular
matrix
(ECM)
interactions,
bridging
the
gap
between
2D
cell
cultures
natural
tissues.
with
spatially
organized
multiple
types
preferred
gaining
comprehensive
insights
into
tissue
pathophysiology
constructing
in
vitro
tissues
disease
because
of
complexities
In
recent
years,
an
assembly
strategy
using
(or
living
building
blocks
has
been
developed
to
construct
complex
spatial
organization.
Here,
a
overview
advances
multispheroid
studies
is
provided.
The
different
mechanisms
techniques,
i.e.,
automated
directed
assembly,
noncontact
remote
programmed
self‐assembly,
introduced.
processing
steps,
advantages,
technical
limitations
existing
methodologies
summarized.
Applications
strategies
modeling,
drug
screening,
engineering,
organogenesis
reviewed.
Finally,
this
review
concludes
by
emphasizing
persistent
issues
future
perspectives,
encouraging
researchers
adopt
techniques
generating
advanced
that
better
resemble
real
Proceedings of the National Academy of Sciences,
Journal Year:
2025,
Volume and Issue:
122(5)
Published: Jan. 30, 2025
The
ionizable
lipid
component
of
nanoparticle
(LNP)
formulations
is
essential
for
mRNA
delivery
by
facilitating
endosomal
escape.
Conventionally,
these
lipids
are
synthesized
through
complex,
multistep
chemical
processes
that
both
time-consuming
and
require
significant
engineering.
Furthermore,
the
development
new
hindered
a
limited
understanding
structure-activity
relationships
effective
delivery.
In
this
work,
we
have
developed
modular
platform
utilizing
Passerini
reaction
to
rapidly
generate
large,
chemically
diverse
libraries
biodegradable
lipids.
This
high-throughput
approach
enables
systematic
exploration
various
components–head
groups,
tails,
spacers–and
their
impacts
on
efficiency.
By
investigating
hydrogen
bonding
potential
between
lipid’s
head
groups
mRNA’s
ribose
phosphate
found
optimizing
methylene
units
linkages
could
enhance
escape
and,
consequently,
efficiencies.
Leveraging
insight,
our
has
led
identification
A4B4-S3,
which
outperforms
current
clinical
benchmark,
SM-102,
in
gene
editing
efficacy
mouse
liver
following
systemic
administration
demonstrates
promise
repeat-dose
protein
replacement
treatments.
work
not
only
offers
rapid,
scalable
method
synthesis
but
also
deepens
relationships,
paving
way
more
therapeutics.
ACS Nano,
Journal Year:
2024,
Volume and Issue:
18(27), P. 17749 - 17763
Published: June 27, 2024
The
rapid
development
of
the
SARS-CoV-2
vaccine
has
been
used
to
prevent
spread
coronavirus
2019
(COVID-19).
However,
ongoing
and
future
pandemics
caused
by
variants
mutations
underscore
need
for
effective
vaccines
that
provide
broad-spectrum
protection.
Here,
we
developed
a
nanoparticle
with
broad
protection
against
divergent
variants.
corresponding
conserved
epitopes
preexisting
neutralizing
(CePn)
antibody
were
presented
on
self-assembling
Helicobacter
pylori
ferritin
generate
CePnF
nanoparticle.
Intranasal
immunization
mice
nanoparticles
induced
robust
humoral,
cellular,
mucosal
immune
responses
long-lasting
immunity.
CePnF-induced
antibodies
exhibited
cross-reactivity
activity
different
coronaviruses
(CoVs).
vaccination
significantly
inhibited
replication
pathology
Delta,
WIV04,
Omicron
strains
in
hACE2
transgenic
and,
thus,
conferred
these
Our
constructed
nanovaccine
targeting
can
serve
as
promising
candidate
universal
vaccine.